Document:

Separation Agreement

 EXHIBIT 10.29 
  
 RITA MEDICAL SYSTEMS, INC. 
  
 SEPARATION AGREEMENT AND MUTUAL RELEASE 

 
 This Separation Agreement and Mutual Release (“Agreement”) is made by and between RITA Medical Systems, Inc.,
a Delaware corporation (the “Company”), and Daniel Balbierz (“Mr. Balbierz” or “Employee”). 
  
 WHEREAS, Mr. Balbierz is employed by the Company pursuant to the terms of an offer letter dated March 19,1998, as amended on April 17, 2002, (the “Offer Letter”); and

  
 WHEREAS, the Company and Mr. Balbierz have mutually agreed to terminate the existing employment
relationship, to release each other from any claims arising from or related to the employment relationship and to enter into a consulting relationship. 
  
 NOW, THEREFORE, in consideration of the mutual promises made herein, the Company and Mr. Balbierz (collectively referred to as the “Parties”) hereby agree as follows:

  
 1.    Termination of Employment.    Mr. Balbierz and the
Company acknowledge and agree that Mr. Balbierz shall voluntarily terminate his employment as Vice President, Research and Development, with the Company effective at the close of business on August 16, 2002 (the “Termination Date”).

  
 2.    Separation Benefits.    In consideration for the
release of claims set forth below and other obligations under this Agreement, and provided this Agreement is signed by Mr. Balbierz and not revoked under Section 7 herein, the Company agrees to provide the following separation benefits to Mr.
Balbierz: 
  
         (a)    The Company shall pay as
severance to Mr. Balbierz a lump sum payment equal to $39,700.00. The severance payment shall be reduced by applicable tax withholding and shall be paid on the first regular payroll date following the Effective Date of this Agreement (as defined in
Section 19 below); and 
  
         (b)    The Company
agrees to retain Mr. Balbierz as a consultant for the period from the Termination Date through the end of the trial in the Company’s patent litigation with RadioTherapeutics Corporation (now owned by Boston Scientific Corporation), which
litigation commenced in August 2001 (the “Consulting Period”), to perform such services as may reasonably be requested in writing by the Company, including, without limitation, the provision of testimony and general advice and
consulting to the Company with regard to patent matters. Mr. Balbierz agrees to make himself reasonably available to provide the requested services during the Consulting Period. Beginning on February 17, 2003, the Company shall pay Mr. Balbierz
$175.00 for each hour of consulting services provided to the Company. Mr. Balbierz shall receive no other compensation for such services. 
  
 3.    Employee Benefits. 
  
         (a)    On or before the Termination Date, the Company shall reimburse Mr. Balbierz for all reasonable business expenses incurred by Mr. Balbierz up until the
Termination Date and submitted for reimbursement in accordance with Company policy. Any expenses incurred by Mr. Balbierz during the Consulting Period shall be reimbursed in accordance with Company policy. 

  
                 (b)    Except as otherwise provided above, Mr. Balbierz shall not be entitled to participate in any of the
Company’s benefit plans or programs offered to employees of the Company after the Termination Date. 
  
 4.    Stock Options. 
  
         (b)    Stock Option.    As of the Termination Date, Mr. Balbierz has been granted a total of 190,700 options to purchase shares of
Company Common Stock (“Options”) 122,102 of which are vested and exercisable and 18,000 of which have been exercised and 12,624 shares of Restricted Common Stock (“Restricted Stock”) 6,312 of which are no longer
subject to a Company repurchase option. The Options and Restricted Stock are subject to the terms of the Company’s 1994 Incentive Stock Plan and 2000 Stock Plan and the related option or restricted stock agreements. Notwithstanding any terms
set forth in the option or restricted stock purchase agreements to the contrary, the Company and Mr. Balbierz have agreed that any unvested options and restricted stock held by Mr. Balbierz on the Termination Date shall continue to vest for a period
of six(6) months following the Termination Date. 
  
 Except as set forth in this Agreement, Mr. Balbierz acknowledges
that as of the Termination Date, Mr. Balbierz has no right, title or interest in or to any shares of the Company’s capital stock, or any other agreement (oral or written) or plan with the Company. 
  
 5.    No Other Payments Due.    Mr. Balbierz and the Company agree that the Company
shall pay to Mr. Balbierz on or before the Termination Date, his accrued salary, accrued vacation and other sums as are due to Mr. Balbierz through such date. By executing this Agreement, Mr. Balbierz hereby acknowledges receipt of all such payments
as received and acknowledges that, in light of the payment by the Company of all wages due to Mr. Balbierz, California Labor Code Section 206.5 is not applicable to the Parties hereto. That section provides in pertinent part as follows:

  
 
	 No employer shall require the execution of any release of any claim or
right on account of wages due, or to become due, or made as
an advance
on wages to be earned, unless payment of such wages has been made.
 

 
  
 6.    Release of
Claims.    In consideration for the obligations of both parties set forth in this Agreement, Mr. Balbierz and the Company, on behalf of themselves, and their respective heirs, executors, officers, directors, employees,
investors, stockholders, administrators and assigns, hereby fully and forever release each other and their respective heirs, executors, officers, directors, employees, investors, stockholders, administrators, predecessor and successor corporations
and assigns, of and from any claim, duty, obligation or cause of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that any of them may possess arising from any omissions, acts or facts that
have occurred up until and including the date of this Agreement including, without limitation: 
  
         (a)    any and all claims relating to or arising from Mr. Balbierz’s employment relationship with the Company and the termination of that relationship;

  
         (b)    any and all claims relating to, or
arising from, Mr. Balbierz’s right to purchase, or actual purchase of shares of stock of the Company; 
  
         (c)    any and all claims for wrongful discharge of employment; breach of contract, both express and implied; breach of a covenant of good faith and fair dealing,
both express and implied, negligent or intentional infliction of emotional distress; negligent or intentional misrepresentation; negligent or intentional interference with contract or prospective economic advantage; negligence; and defamation;

 
 -2- 

  
         (d)    any
and all claims for violation of any federal, state or municipal statute, including, but not limited to, Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Age Discrimination in Employment Act of 1967, the Americans with
Disabilities Act of 1990, and the California Fair Employment and Housing Act; 
  
         (e)    any and all claims arising out of any other laws and regulations relating to employment or employment discrimination; and 
  
         (f)    any and all claims for attorneys’ fees and costs.

  
 The Company and Mr. Balbierz agree that the release set forth in this Section 6 shall be and remain in effect in
all respects as a complete general release as to the matters released. This release does not extend to any obligations incurred or specified under this Agreement. 
  
 7.    Acknowledgment of Waiver of Claims under ADEA.    Mr. Balbierz acknowledges that he is waiving and releasing any
rights he may have under the Age Discrimination in Employment Act of 1967 (“ADEA”) and that this waiver and release is knowing and voluntary. Mr. Balbierz and the Company agree that this waiver and release does not apply to any
rights or claims that may arise under ADEA after the Effective Date of this Agreement. Mr. Balbierz acknowledges that the consideration given for this waiver and release Agreement is in addition to anything of value to which Mr. Balbierz was already
entitled. Mr. Balbierz further acknowledges that he has been advised by this writing that (a) he should consult with an attorney prior to executing this Agreement; (b) he has at least twenty-one (21) days within which to consider this
Agreement; (c) he has seven (7) days following his execution of this Agreement to revoke the Agreement (the “Revocation Period”). This Agreement shall not be effective until the Revocation Period has expired. 

 
 8.    Civil Code Section 1542.    The Parties represent that they are not
aware of any claim by either of them other than the claims that are released by this Agreement. Mr. Balbierz and the Company acknowledge that they are familiar with the provisions of California Civil Code Section 1542, which provides as follows:

  
 A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH  THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN
 HIS FAVOR AT THE TIME OF EXECUTING THE RELEASE,  WHICH IF KNOWN BY HIM MUST HAVE MATERIALLY  AFFECTED HIS SETTLEMENT WITH THE DEBTOR. 
  
 Mr. Balbierz and the Company, being aware of said Code section, agree to expressly waive any rights they may have thereunder, as well as under any other statute or common law principles of similar
effect. 
  
 9.    Employee Covenants. 
  
         (a)    General.    Mr. Balbierz
agrees that for all periods described in this Agreement, he shall continue to conduct himself in a professional manner that is supportive of the business of the Company. 
  
         (b)    Confidentiality.    Mr. Balbierz and the Company agree to
maintain in strict confidence the existence of this Agreement, the contents and terms of this Agreement, and the consideration for this Agreement (hereinafter collectively referred to as “Settlement Information”) and each Party
further agrees to take every reasonable precaution to prevent disclosure of any Settlement 

 
 -3- 

 Information to any person or entity, other than Mr. Balbierz’s spouse, family members, tax and legal advisors and the Company’s
accounting and legal advisors, unless otherwise required to disclose such information by law or by a governmental entity.  
  
         (c)    Nondisclosure.    Mr. Balbierz represents and warrants that he has not breached his obligations to the Company under the
terms of the Confidential Information and Invention Assignment Agreement entered into between Mr. Balbierz and the Company on March 25, 1998 (the “Confidentiality Agreement”), a copy of which is attached hereto as Exhibit A.
Mr. Balbierz understands and agrees that his obligations to the Company under the Confidentiality Agreement survive the termination of his relationship with the Company under this Agreement; provided, however, that the Company and Mr.
Balbierz hereby agree that Section 4(b) of the Confidentiality Agreement shall be amended as provided below: 
  
 “Assignment of Inventions.    I agree that I will promptly make full written disclosure to the Company, will hold in trust for the sole right and benefit of the Company and hereby assign to the
Company, or its designee, all my right, title and interest throughout the world in and to any and all inventions, original works of authorship, developments, concepts, know-how, improvements or trade secrets, whether or not patentable or registrable
under copyright or similar laws, which I may solely or jointly conceive or develop or reduce to practice, or cause to be conceived or developed or reduced to practice, which use radiofrequency energy to treat solid cancerous or benign tumors, during
the period of time in which I am employed by or a consultant of the Company (collectively referred to as “Inventions”), except as provided in Section 4(e) below. I further acknowledge that all Inventions which are made by me (solely
or jointly with others) within the scope of and during the period of my Relationship with the Company are “works made for hire” (to the greatest extent permitted by applicable law) and are compensated by my salary (if I am an
employee) or by such amounts paid to me under any applicable consulting agreement or consulting arrangements (if I am a consultant), unless regulated otherwise by the mandatory law of the state of California.” 
  
 10.    Non-Disparagement.    Each Party agrees to refrain from any disparagement,
defamation, slander of the other, or tortious interference with the contracts and relationships of the other. 
  
 11.    Employment References.    The Company and Mr. Balbierz agree that upon request for references from prospective future employers, the Company shall direct all such inquiries
to its Human Resources Department who shall then provide information only with respect to Mr. Balbierz’s length of employment and last position held with the Company. 
  
 12.    Authority.    The Company represents and warrants that the undersigned has the authority to act on behalf of
the Company and to bind the Company and all who may claim through it to the terms and conditions of this Agreement. Mr. Balbierz represents and warrants that he has the capacity to act on his own behalf and on behalf of all who might claim through
his to bind them to the terms and conditions of this Agreement. Each Party warrants and represents that there are no liens or claims of lien or assignments in law or equity or otherwise of or against any of the claims or causes of action released
herein. 
  
 13.    No Representations.    Neither Party has
relied upon any representations or statements made by the other Party hereto which are not specifically set forth in this Agreement. 
  
 14.    Severability.    In the event that any provision hereof becomes or is declared by a court or other tribunal of competent jurisdiction to be illegal, unenforceable
or void, this Agreement shall continue in full force and effect without said provision. 

 
 -4- 

  
 15.    Arbitration.    The
Parties shall attempt to settle all disputes arising in connection with this Agreement through good faith consultation. In the event no agreement can be reached on such dispute within fifteen (15) days after notification in writing by either Party
to the other concerning such dispute, the dispute shall be settled by binding arbitration to be conducted in Alameda County before the American Arbitration Association under its California Employment Dispute Resolution Rules, or by a judge to be
mutually agreed upon. The arbitration decision shall be final, conclusive and binding on both Parties and any arbitration award or decision may be entered in any court having jurisdiction. The Parties agree that the prevailing party in any
arbitration shall be entitled to injunctive relief in any court of competent jurisdiction to enforce the arbitration award. The Parties further agree that the prevailing Party in any such proceeding shall be awarded reasonable attorneys’ fees
and costs. This Section 15 shall not apply to the Confidentiality Agreement. The parties hereby waive any rights they may have to trial by jury in regard to arbitrable claims. 
  
 16.    Entire Agreement.    This Agreement, with the exhibit attached hereto, represents the entire agreement and
understanding between the Company and Mr. Balbierz concerning Mr. Balbierz’s separation from the Company, and supersede and replace any and all prior agreements and understandings concerning Mr. Balbierz’s relationship with the Company and
his compensation by the Company. 
  
 17.    No Oral
Modification.    This Agreement may only be amended in writing signed by Mr. Balbierz and the Company. 
  
 18.    Governing Law.    This Agreement shall be governed by the laws of the State of California, without regard to its conflicts of law provisions. 

 
 19.    Effective Date.    This Agreement is effective upon the expiration
of the Revocation Period described in Section 7 and such date is referred to herein as the “Effective Date.” 
  
 20.    Counterparts.    This Agreement may be executed in counterparts, and each counterpart shall have the same force and effect as an original and shall constitute an effective,
binding agreement on the part of each of the undersigned. 
  
 21.    Assignment.    This Agreement may not be assigned by Mr. Balbierz or the Company without the prior written consent of the other party. Notwithstanding the foregoing, this
Agreement may be assigned by the Company to a corporation controlling, controlled by or under common control with the Company without the consent of Mr. Balbierz. 
  
 22.    Breach of the Agreement.    Mr. Balbierz acknowledges that upon his breach of this Agreement or the
Confidentiality Agreement, the Company would sustain irreparable harm from such breach, and, therefore, Mr. Balbierz agrees that in addition to any other remedies which the Company may have under this Agreement or otherwise, the Company shall be
entitled to obtain equitable relief, including specific performance and injunctions, restraining his from committing or continuing any such violation of the Agreement or the Confidentiality Agreement. Mr. Balbierz acknowledges and agrees that upon
his material or intentional breach of any of the provisions of the Agreement (including Section 9) or the Confidentiality Agreement, in addition to any other remedies the Company may have under this Agreement or otherwise, the Company’s
obligations to provide benefits to Employee, as described in this Agreement, including without limitation those benefits provided in Sections 2, 3 and 4 shall immediately terminate. 

 
 -5- 

  
 23.    Voluntary Execution of
Agreement.    This Agreement is executed voluntarily and without any duress or undue influence on the part or behalf of the Parties hereto, with the full intent of releasing all claims. The Parties acknowledge that:

  
         (a)    they have read this Agreement;

  
         (b)    they have been represented in the
preparation, negotiation, and execution of this Agreement by legal counsel of their own choice or that they have voluntarily declined to seek such counsel; 
  
         (c)    they understand the terms and consequences of this Agreement and of the releases it contains; and 
  
         (d)    they are fully aware of the legal and binding effect of this
Agreement. 
  
 IN WITNESS WHEREOF, the Parties have executed this Separation Agreement and Mutual Release on the
respective dates set forth below. 
  
 
	  	  	 RITA MEDICAL SYSTEMS, INC.
 
	 
	 Dated as of July 30, 2002
 	  	 By:
 	  	 /s/    BARRY CHESKIN
 

	  	  	 Title:
 	  	 President and Chief Executive Officer
 

	 
	  	  	 DANIEL BALBIERZ, an individual
 
	 Dated as of July 30, 2002
 	  	 /s/    DANIEL BALBIERZ
 

 

 
 -6- 

  
 EXHIBIT A 
  
 CONFIDENTIALITY AGREEMENTChange of Control Agreement

  
 EXHIBIT 10.30 
  
 CHANGE OF CONTROL AGREEMENT 
  
 This
Change of Control Agreement (the “Agreement”) is made and entered into effective as of July 29, 2002, by and between Stephen J. Williams (the “Employee”) and RITA Medical Systems, Inc., a Delaware corporation (the
“Company”). 
  
 RECITALS 
  
 A.    It is understood that another company or other entity may from time to time consider the possibility of acquiring the Company or that a change in control may otherwise occur,
with or without the approval of the Company’s Board of Directors (the “Board”). The Board has identified the Employee, an officer of the Company, as a key employee whose continued employment with the Company is critical to the
Company’s future success and has determined that it is important to provide Employee with an incentive to continue his or her employment with the Company in the event that the Company consummates a Change of Control transaction. For purposes of
this Agreement, this shall include Employee’s employment in a majority-owned subsidiary or other surviving entity of an acquiring Company. 
  
 B.    To accomplish the foregoing objectives, the Board of Directors has directed the Company, upon execution of this Agreement by the Employee, to agree to the terms provided in
this Agreement. 
  
 C.    The Board believes that it is imperative to provide the Employee with
certain benefits upon a Change of Control and, under certain circumstances, upon termination of the Employee’s employment in connection with a Change of Control, which benefits are intended to provide the Employee with financial security and
provide sufficient income and encouragement to the Employee to remain with the Company notwithstanding the possibility of a Change of Control. 
  
 D.    To accomplish the foregoing objectives, the Board of Directors has directed the Company, upon execution of this Agreement by the Employee, to agree to the terms provided in
this Agreement. 
  
 E.    Certain capitalized terms used in the Agreement are defined in Section
3 below. 
  
 In consideration of the mutual covenants contained in this Agreement, and in consideration of the
continuing employment of Employee by the Company, the parties agree as follows: 
  
         1.    At-Will Employment.    The Company and the Employee acknowledge that the Employee’s employment is and shall continue to be
at-will, as defined under applicable law. If the Employee’s employment terminates for any reason, including (without limitation) any termination prior to a Change of Control, the Employee shall not be entitled to any payments or benefits, other
than as provided by this Agreement, or as may otherwise be available in 

 accordance with the terms of the Company’s established employee plans and written policies at the time of termination. The terms of this
Agreement shall terminate upon the earlier of (i) the date on which Employee ceases to be employed as an officer of the Company, other than as a result of an involuntary termination by the Company without Cause, (ii) the date that all obligations of
the parties hereunder have been satisfied, or (iii) twelve (12) months after a Change of Control. A termination of the terms of this Agreement pursuant to the preceding sentence shall be effective for all purposes, except that such termination shall
not affect the payment or provision of compensation or benefits on account of a termination of employment occurring prior to the termination of the terms of this Agreement. 
  
         2.    Change of Control. 
  
                 (a)    Stock Options and Restricted
Stock.    Subject to Section 4 below, in the event of a Change of Control, on the effective date of the transaction, fifty percent (50%) of all unvested options to purchase the Company’s securities held by the Employee
(the “Option”) prior to the effective date of the Change of Control transaction shall become fully vested and immediately exercisable and shall be exercisable to the extent so vested in accordance with the provisions of the Option
Agreement and Plan pursuant to which such Option was granted and repurchase rights of the Company with respect to fifty percent (50%) of the shares of restricted stock held by the Employee purchased by the Employee pursuant to the terms of a Stock
Purchase Agreement shall immediately lapse. In addition, on each one month anniversary of the effective date of the Change of Control transaction  1/12 of all remaining unvested options held by the Employee shall become fully vested and immediately exercisable and repurchase rights of the Company with respect to  1/12 of all remaining shares of restricted stock held by Employee shall lapse. 
  
                 (b)    Termination
Following A Change of Control.    If the Employee’s employment with the Company is involuntarily terminated at any time within twelve (12) months after a Change of Control all unvested options held by the Employee shall
become fully vested and immediately exercisable and shall be exercisable to the extent so vested in accordance with the provisions of the Option Agreement and Plan pursuant to which such Option was granted and repurchase rights of the Company with
respect to all of the shares of restricted stock held by the Employee purchased by the Employee pursuant to the terms of a Stock Purchase Agreement shall immediately lapse. 
  
                         (i)    Voluntary Resignation and Termination for
Cause.    If the Employee voluntarily resigns from the Company or is terminated for Cause following the Change of Control, then the Employee shall not be entitled to any acceleration of the vesting of his or her unvested
options or lapse of repurchase rights with respect to his or her restricted stock. 
  
         3.    Definition of Terms.    The following terms referred to in this Agreement shall have the following meanings: 

 
                 (a)    Change of Control.    “Change of Control” shall mean the consummation of
any of the following events: 

 
 -2- 

  
 (i)    Ownership.    Any
“Person” (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) is or becomes the “Beneficial Owner” (as defined in Rule 13d-3 under said Act), directly or indirectly, of securities
of the Company representing fifty percent (50%) or more of the total voting power represented by the Company’s then outstanding voting securities without the approval of the Board of Directors of the Company; or 
  
 (ii)    Merger/Sale of Assets.    A merger or consolidation of the Company whether or not
approved by the Board of Directors of the Company, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by
being converted into voting securities of the surviving entity) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity outstanding immediately after such merger or
consolidation, or the stockholders of the Company approve a plan of complete liquidation of the Company or an agreement for the sale or disposition by the Company of all or substantially all of the Company’s assets. 
  
 (b)    Cause.    “Cause” shall mean (i) gross negligence or willful misconduct in
the performance of the Employee’s duties to the Company where such gross negligence or willful misconduct has resulted or is likely to result in substantial and material damage to the Company or its subsidiaries, (ii) repeated unexplained or
unjustified absence from the Company, (iii) a material and willful violation of any federal or state law; (iv) commission of any act of fraud with respect to the Company; or (v) conviction of a felony or a crime involving moral turpitude causing
material harm to the standing and reputation of the Company, in each case as determined in good faith by the Board of Directors of the Company. 
  
 (c)    Involuntary Termination.    “Involuntary Termination” shall include any termination by the Company other than for Cause and the
Employee’s voluntary termination, upon 30 days prior written notice to the Company, following (i) a material reduction or change in job duties, responsibilities and requirements inconsistent with the Employee’s position with the Company
and the Employee’s prior duties, responsibilities and requirements, taking into account the differences in job title and duties that are normally occasioned by reason of an acquisition of one company by another and that do not actually result
in a material change in duties, responsibilities and requirements inconsistent with an employee’s prior position with the acquired company; (ii) any reduction of the Employee’s base and cash bonus compensation (other than in connection
with a general decrease in base salaries for most similarly situated employees of the successor corporation); or (iii) the Employee’s refusal to relocate to a location more than 50 miles from the Company’s current location. 

 

	 	4.
	 
	Limitation on Payments. 
 

  
 (a)    In the event that the severance benefits provided for in this Agreement to the Employee (i) constitute “parachute payments” within the meaning of Section 280G of the Internal Revenue Code
of 1986, as amended (the “Code”) and (ii) but for this Section, would be subject to the excise tax imposed by Section 4999 of the Code, then the Employee’s benefits under Section 2 shall be payable either: (i) in full, or (ii) as to
such lesser
 

 
 -3- 

 
amount which would result in no portion of such severance benefits being subject to excise tax under Section 4999 of the Code, whichever of the foregoing amounts, taking into account the
applicable federal, state and local income taxes and the excise tax imposed by Section 4999, results in the receipt by the Employee on an after-tax basis, of the greatest amount of benefits under Section 2, notwithstanding that all or some portion
of such benefits may be taxable under Section 4999 of the Code. Unless the Company and the Employee otherwise agree in writing, any determination required under this Section 4 shall be made in writing by the Company’s independent public
accountants (the “Accountants”), whose determination shall be conclusive and binding upon the Employee and the Company for all purposes. For purposes of making the calculations required by this Section 4, the Accountants may make
reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Section 280G and 4999 of the Code. The Company and the Employee shall furnish to the
Accountants such information and documents as the Accountants may reasonably request in order to make a determination under this Section. The Company shall bear all costs the Accountants may reasonably incur in connection with any calculations
contemplated by this Section 4. 
  
 (b)    The payment of severance benefits provided for in this
Agreement shall be subject to all applicable income, employment and social tax rules and regulations. 
  
 5.    Successors.    Any successor to the Company (whether direct or indirect and whether by purchase, lease, merger, consolidation, liquidation or otherwise) to all or substantially all
of the Company’s business and/or assets shall assume the obligations under this Agreement and agree expressly to perform the obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform
such obligations in the absence of a succession. The terms of this Agreement and all of the Employee’s rights hereunder shall inure to the benefit of, and be enforceable by, the Employee’s personal or legal representatives, executors,
administrators, successors, heirs, distributees, devisees and legatees. 
  
 6.    Notice.    Notices and all other communications contemplated by this Agreement shall be in writing and shall be deemed to have been duly given when personally delivered or when
mailed by U.S. registered or certified mail, return receipt requested and postage prepaid. Mailed notices to the Employee shall be addressed to the Employee at the home address which the Employee most recently communicated to the Company in writing.
In the case of the Company, mailed notices shall be addressed to its corporate headquarters, and all notices shall be directed to the attention of its Secretary. 
  
 7.    Miscellaneous Provisions. 
  
 (a)    No Duty to Mitigate.    The Employee shall not be required to mitigate the amount of any payment contemplated by this Agreement (whether by seeking new employment or in any other
manner), nor, except as otherwise provided in this Agreement, shall any such payment be reduced by any earnings that the Employee may receive from any other source. 

 
 -4- 

  
 (b)    Waiver.    No provision of
this Agreement shall be modified, waived or discharged unless the modification, waiver or discharge is agreed to in writing and signed by the Employee and by an authorized officer of the Company (other than the Employee). No waiver by either party
of any breach of, or of compliance with, any condition or provision of this Agreement by the other party shall be considered a waiver of any other condition or provision or of the same condition or provision at another time. 
  
 (c)    Whole Agreement.    No agreements, representations or understandings (whether oral
or written and whether express or implied) which are not expressly set forth in this Agreement have been made or entered into by either party with respect to the subject matter hereof. This Agreement supersedes any agreement of the same title and
concerning similar subject matter dated prior to the date of this Agreement, and by execution of this Agreement both parties agree that any such predecessor agreement shall be deemed null and void. 
  
 (d)    Choice of Law.    The validity, interpretation, construction and performance of this
Agreement shall be governed by the laws of the State of California without reference to conflict of laws provisions. 
  
 (e)    Severability.    If any term or provision of this Agreement or the application thereof to any circumstance shall, in any jurisdiction and to any extent, be invalid or
unenforceable, such term or provision shall be ineffective as to such jurisdiction to the extent of such invalidity or unenforceability without invalidating or rendering unenforceable the remaining terms and provisions of this Agreement or the
application of such terms and provisions to circumstances other than those as to which it is held invalid or unenforceable, and a suitable and equitable term or provision shall be substituted therefor to carry out, insofar as may be valid and
enforceable, the intent and purpose of the invalid or unenforceable term or provision. 
  
 (f)    Arbitration.    Any dispute or controversy arising under or in connection with this Agreement may be settled at the option of either party by binding arbitration in the County of
Santa Clara, California, in accordance with the rules of the American Arbitration Association then in effect. Judgment may be entered on the arbitrator’s award in any court having jurisdiction. Punitive damages shall not be awarded.

  
 (g)    Legal Fees and Expenses.    The parties shall each bear
their own expenses, legal fees and other fees incurred in connection with this Agreement. 
  
 (h)    No Assignment of Benefits.    The rights of any person to payments or benefits under this Agreement shall not be made subject to option or assignment, either by voluntary
or involuntary assignment or by operation of law, including (without limitation) bankruptcy, garnishment, attachment or other creditor’s process, and any action in violation of this subsection (h) shall be void. 
  
 (i)    Employment Taxes.    All payments made pursuant to this Agreement will be subject to
withholding of applicable income and employment taxes. 

 
 -5- 

  
 (j)    Assignment by the
Company.    The Company may assign its rights under this Agreement to an affiliate, and an affiliate may assign its rights under this Agreement to another affiliate of the Company or to the Company; provided, however, that no
assignment shall be made if the net worth of the assignee is less than the net worth of the Company at the time of assignment. In the case of any such assignment, the term “Company” when used in a section of this Agreement shall mean the
corporation that actually employs the Employee. 
  
 (k)    Counterparts.    This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together will constitute one and the same instrument.

  
 (SIGNATURE PAGE FOLLOWS) 

 
 -6- 

  
 IN WITNESS WHEREOF, each of the parties has executed this Agreement, in the case
of the Company by its duly authorized officer, as of the day and year first above written. 
  
 
	  	 	 RITA MEDICAL SYSTEMS, INC.
 	 	  	 	  	 	 STEPHEN J. WILLIAMS
 
	 
	 By:
 	 	 /S/    BARRY
CHESKIN        
 
	 	  	 	  	 	 /S/    STEPHEN J.
WILLIAMS        
 

	 Title:
 	 	 President and Chief Executive Officer
 	 	  	 	  	 	  

 

 
 -7-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00045-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00045-of-00352.parquet"}]]